EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Morning Salivary Cortisone Versus Serum Cortisol in the Overnight Dexamethasone Suppression Test (ODNST): Evaluation in a Clinical Setting

Mathilde Mordaunt, Adrian Heald iD, Waseem Majeed, Rupinder Kochhar, Akheel Syed, Rajshekhar N Mudaliar, Ramadan Alshames, Fahmy Hanna, David Marshall, Brian Keevil, Anthony A Fryer

Clinical Endocrinology · 2025

DOI: 10.1111/cen.15233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, 2025. Verfasst von Mathilde Mordaunt und 10 weiteren Autor:innen. Beteiligte Einrichtung: University of Manchester, Manchester, UK. Hauptthemen laut MEDLINE: Hydrocortisone, Dexamethasone, Saliva, Cortisone. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Saliva hormone measurement is increasingly being applied in everyday clinical practice. In relation to salivary cortisone measurement, there is a particular advantage, with minimal chance of cross‐reaction with prescribed glucocorticoids and greater convenience. We evaluated the utility of salivary cortisone measurement in patients undergoing an overnight dexamethasone suppression test (ONDST).

Methods

Individuals undergoing an ONDST had parallel measurement of serum cortisol and salivary cortisone at 0900 following midnight dexamethasone (1 mg). Salivary cortisone was measured by electrospray positive liquid chromatography tandem mass spectrometry. The threshold for adequate suppression of salivary cortisone was< 2.7nmol/L; serum cortisol was< 50nmol/L.

Results

Results for 34 individuals which included 21% men (mean age 49.4 years) and 79% women (mean age 56.7 years) were analysed. Serum cortisol did not suppress in 22/34 cases. Salivary cortisone did not suppress in two of the cases where cortisol did suppress. We found a strong correlation between 0900 salivary cortisone and serum cortisol after 1 mg ONDST ( r 2 = 0.65, p = 0.009). When performance of post‐dexamethasone salivary cortisone (< 2.7nmol/L) alone in relation to suppression of serum cortisol (< 50nmol/L) was analysed all but 2 individuals were correctly classified. They had values for post dexamethasone salivary cortisone/serum cortisol of respectively 5.9/23 nmol/L (presented with unexplained fatigue, case 25) and 7/32 nmol/L (investigated for cyclical Cushing's Syndrome that was excluded, case 29). Agreement was 94.1%, kappa 0.87, p < 0.0001. The sensitivity of salivary cortisone for potential Cushing's syndrome as indicated by the post‐dexamethasone 0900 serum cortisol was 100% (all cases of potential cortisol excess (0900 cortisol > 50nmol/L) were picked up) and specificity of 84.6% with a positive predictive value of 90.5% of salivary cortisone (using serum cortisol as the standard) and negative predictive value of 100% in relation to ruling out cortisol excess.

Conclusion

We have provided further evidence that ONDST salivary cortisone has potential to be the first‐line test for suspected Cushing's syndrome, not requiring venepuncture or attendance at hospital, with 100% sensitivity and reasonable specificity. Application of the salivary cortisone test has the potential for significant savings of money and time in this and other contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrocortisoneDexamethasoneSalivaCortisoneHumansFemaleMiddle AgedMaleAdultAgedCircadian Rhythm

Stichwörter der Autor:innen

adrenal insufficiencyovernight dexamethasone suppfession testsalivary cortisonesensitivityspecificity

Substanzen

HydrocortisoneDexamethasoneCortisone

Autor:innen und Institutionen

  • University of Manchester, Manchester, UK.
  • Department of Endocrinology and Diabetes, Salford Royal Hospital, Salford, UK.
  • Biochemistry Department, Faculty of Dentistry, Tripoli University, Tripoli, Libya.
  • Department of Endocrinology and Diabetes, University Hospital North Midlands, Stoke on-Trent, UK.
  • Department of Biochemistry, Manchester University NHS Trust, Manchester, UK.
  • Keele University, Keele, UK.

ORCID-Profile: Adrian Heald

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Mordaunt, M., Heald, A., Majeed, W., Kochhar, R., Syed, A., Mudaliar, R. N., Alshames, R., Hanna, F., Marshall, D., Keevil, B., & Fryer, A. A. (2025). Morning Salivary Cortisone Versus Serum Cortisol in the Overnight Dexamethasone Suppression Test (ODNST): Evaluation in a Clinical Setting. Clinical Endocrinology. https://doi.org/10.1111/cen.15233

Vancouver

Mordaunt M, Heald A, Majeed W, Kochhar R, Syed A, Mudaliar RN, et al. Morning Salivary Cortisone Versus Serum Cortisol in the Overnight Dexamethasone Suppression Test (ODNST): Evaluation in a Clinical Setting. Clinical Endocrinology. 2025. doi:10.1111/cen.15233

BibTeX
@article{Mordaunt2025,
  author = {Mordaunt, Mathilde and Heald, Adrian and Majeed, Waseem and Kochhar, Rupinder and Syed, Akheel and Mudaliar, Rajshekhar N and Alshames, Ramadan and Hanna, Fahmy and Marshall, David and Keevil, Brian and Fryer, Anthony A},
  title = {Morning Salivary Cortisone Versus Serum Cortisol in the Overnight Dexamethasone Suppression Test (ODNST): Evaluation in a Clinical Setting},
  journal = {Clinical Endocrinology},
  year = {2025},
  doi = {10.1111/cen.15233}
}
Kostenlos starten →